| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Case of Anti–PD-L1-associated Remitting Seronegative Symmetric Synovitis With Pitting Edema
|
Redman, Jason M.
|
|
2019
|
17 |
3 |
p. e549-e552
|
artikel
|
| 2 |
A Case of Heavily Pretreated Metastatic Germ Cell Tumor With Ongoing Long-term Complete Response After Gemcitabine Treatment
|
Vicier, Cécile
|
|
2019
|
17 |
3 |
p. e485-e487
|
artikel
|
| 3 |
Accuracy of CAPRA-S Score for Predicting Long-Term Biochemical Progression After Radical Prostatectomy
|
Hernández Hernández, Casandra
|
|
2019
|
17 |
3 |
p. e645-e649
|
artikel
|
| 4 |
A Complete Response After Pseudo-progression: Pembrolizumab for Metastatic Squamous Cell Carcinoma (SCC) of the Bladder
|
Kao, Chester
|
|
2019
|
17 |
3 |
p. e672-e677
|
artikel
|
| 5 |
A National Survey of Radiation Oncologists and Urologists on Perceived Attitudes and Recommendations of Active Surveillance for Low-Risk Prostate Cancer
|
Kim, Simon P.
|
|
2019
|
17 |
3 |
p. e472-e481
|
artikel
|
| 6 |
Angiomyolipoma of the Adrenal Glands
|
Kord Valeshabad, Ali
|
|
2019
|
17 |
3 |
p. e553-e555
|
artikel
|
| 7 |
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205
|
Hotte, Sebastien J.
|
|
2019
|
17 |
3 |
p. 201-208.e1
|
artikel
|
| 8 |
Application of Urinary Volatile Organic Compounds (VOCs) for the Diagnosis of Prostate Cancer
|
Gao, Qin
|
|
2019
|
17 |
3 |
p. 183-190
|
artikel
|
| 9 |
A Simple Immunohistochemical Panel Could Predict and Correlate to Clinicopathologic and Molecular Subgroups of Urinary Bladder Urothelial Carcinoma
|
Makboul, Rania
|
|
2019
|
17 |
3 |
p. e712-e719
|
artikel
|
| 10 |
Assessing Outcomes and Prognostic Factors for First-Line Therapy in Elderly Patients With Metastatic Renal Cell Carcinoma: Real-Life Data From a Single United Kingdom Institution
|
Uccello, Mario
|
|
2019
|
17 |
3 |
p. e658-e663
|
artikel
|
| 11 |
Association Between Hospitals’ Risk-Adjusted Emergency Department Visits and Survival and Costs in Kidney Cancer Patients Undergoing Nephrectomy
|
Segel, Joel E.
|
|
2019
|
17 |
3 |
p. e650-e657
|
artikel
|
| 12 |
Cardiovascular and Metabolic Toxicity of Abiraterone in Castration-resistant Prostate Cancer: Post-marketing Experience
|
Tsao, Phoebe A.
|
|
2019
|
17 |
3 |
p. e592-e601
|
artikel
|
| 13 |
Contemporary Comparison of Clinicopathologic Characteristics and Survival Outcomes of Prostate Ductal Carcinoma and Acinar Adenocarcinoma: A Population-Based Study
|
Knipper, Sophie
|
|
2019
|
17 |
3 |
p. 231-237.e2
|
artikel
|
| 14 |
Contemporary Survival Rates for Muscle-Invasive Bladder Cancer Treated With Definitive or Non-Definitive Therapy
|
Gild, Philipp
|
|
2019
|
17 |
3 |
p. e488-e493
|
artikel
|
| 15 |
Corrigendum
|
|
|
2019
|
17 |
3 |
p. 240
|
artikel
|
| 16 |
Current Therapies of Wilms Tumors in the Adult: Diagnostic Considerations and Treatment Challenges
|
Bradtke, Marlon
|
|
2019
|
17 |
3 |
p. e522-e525
|
artikel
|
| 17 |
Determinants of Guideline-Based Treatment in Patients With cT1 Bladder Cancer
|
Balakrishnan, Ashwin S.
|
|
2019
|
17 |
3 |
p. e461-e471
|
artikel
|
| 18 |
Editorial Board
|
|
|
2019
|
17 |
3 |
p. A5
|
artikel
|
| 19 |
Effectiveness of Platinum-Based Chemotherapy in Patients With Metastatic Prostate Cancer: Systematic Review and Meta-analysis
|
Leal, Frederico
|
|
2019
|
17 |
3 |
p. e627-e644
|
artikel
|
| 20 |
Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score–Matched Analysis
|
Chung, Ho Seok
|
|
2019
|
17 |
3 |
p. e394-e407
|
artikel
|
| 21 |
Evaluating the Potential Role of Salvage Vesiculectomy for Prostate Cancer Recurrence
|
Wymer, Kevin M.
|
|
2019
|
17 |
3 |
p. e536-e540
|
artikel
|
| 22 |
Evaluation of Cause of Death After Radical Cystectomy for Patients With Bladder Cancer: The Impact of Age at the Time of Surgery
|
Moschini, Marco
|
|
2019
|
17 |
3 |
p. e541-e548
|
artikel
|
| 23 |
Genetic Polymorphism in Sex Hormone-binding Globulin With a Prognosis of Androgen Deprivation Therapy in Metastatic Prostate Cancer Among Japanese Men
|
Shiota, Masaki
|
|
2019
|
17 |
3 |
p. e387-e393
|
artikel
|
| 24 |
How Are Patients With Prostate Cancer Managing Androgen Deprivation Therapy Side Effects?
|
Wibowo, Erik
|
|
2019
|
17 |
3 |
p. e408-e419
|
artikel
|
| 25 |
Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell Carcinoma
|
Labriola, Matthew K.
|
|
2019
|
17 |
3 |
p. e513-e521
|
artikel
|
| 26 |
Impact of Disagreement Between Two Risk Group Models on Prognosis in Patients With Metastatic Renal-Cell Carcinoma
|
Okita, Kazutaka
|
|
2019
|
17 |
3 |
p. e440-e446
|
artikel
|
| 27 |
Incident Chronic Kidney Disease After Radical Nephrectomy for Renal Cell Carcinoma
|
Ellis, Robert J.
|
|
2019
|
17 |
3 |
p. e581-e591
|
artikel
|
| 28 |
Induction Chemotherapy Followed by Surgery Versus Upfront Radical Cystectomy in Patients With Clinically Node-positive Muscle-invasive Bladder Cancer
|
Pak, Sahyun
|
|
2019
|
17 |
3 |
p. e420-e428
|
artikel
|
| 29 |
Is Axitinib Still a Valid Option for mRCC in the Second-Line Setting? Prognostic Factor Analyses From the AXIS Trial
|
Bracarda, Sergio
|
|
2019
|
17 |
3 |
p. e689-e703
|
artikel
|
| 30 |
Is Malignant Germ-Cell Tumor Associated With Cowden Syndrome?
|
Rushin, Leah
|
|
2019
|
17 |
3 |
p. e429-e432
|
artikel
|
| 31 |
Low Expression of ATM Indicates a Poor Prognosis in Clear Cell Renal Cell Carcinoma
|
Ren, Wenbiao
|
|
2019
|
17 |
3 |
p. e433-e439
|
artikel
|
| 32 |
Low Rate of Cancer Events After Partial Nephrectomy for Renal Cell Carcinoma: Clinicopathologic Analysis of 1994 Cases with Emphasis on Definition of “Recurrence”
|
Bertolo, Riccardo
|
|
2019
|
17 |
3 |
p. 209-215.e1
|
artikel
|
| 33 |
Metastatic Chromophobe Renal Cell Carcinoma: Presence or Absence of Sarcomatoid Differentiation Determines Clinical Course and Treatment Outcomes
|
Ged, Yasser
|
|
2019
|
17 |
3 |
p. e678-e688
|
artikel
|
| 34 |
Metastatic Clear-cell Renal Cell Carcinoma With a Long-term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 Expression
|
Kammerer-Jacquet, Solène-Florence
|
|
2019
|
17 |
3 |
p. 169-176.e1
|
artikel
|
| 35 |
Microsatellite Instability May Predict Response to Sipuleucel-T in Patients With Prostate Cancer
|
Zhang, Kevin Juan
|
|
2019
|
17 |
3 |
p. 238-239
|
artikel
|
| 36 |
Myalgia and Arthralgia Immune-related Adverse Events (irAEs) in Patients With Genitourinary Malignancies Treated With Immune Checkpoint Inhibitors
|
Ornstein, Moshe C.
|
|
2019
|
17 |
3 |
p. 177-182
|
artikel
|
| 37 |
Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative Analysis
|
Field, Charles A.
|
|
2019
|
17 |
3 |
p. e505-e512
|
artikel
|
| 38 |
New-Generation Hormone Therapies in Nonmetastatic Castration-Resistant Prostate Cancer: Why, Who, When
|
Roviello, Giandomenico
|
|
2019
|
17 |
3 |
p. e534-e535
|
artikel
|
| 39 |
Patterns of Presentation and Treatment Outcomes of Non–clear-cell Renal Cell Carcinoma and Sarcomatoid Renal Cell Carcinoma Patients in 2 Tertiary Referral Centers in Sydney, Australia
|
Naher, Sayeda
|
|
2019
|
17 |
3 |
p. e565-e569
|
artikel
|
| 40 |
PD-1/PD-L1 Combinations in Advanced Urothelial Cancer: Rationale and Current Clinical Trials
|
Hsu, Miles M.
|
|
2019
|
17 |
3 |
p. e618-e626
|
artikel
|
| 41 |
Prostate Cancer National Summit’s Call to Action
|
Heath, Elisabeth I.
|
|
2019
|
17 |
3 |
p. 161-168
|
artikel
|
| 42 |
Real-world Effectiveness and Safety of Pazopanib in Patients With Intermediate Prognostic Risk Advanced Renal Cell Carcinoma
|
Procopio, Giuseppe
|
|
2019
|
17 |
3 |
p. e526-e533
|
artikel
|
| 43 |
Real-world Experience of Cabozantinib as Second- or Subsequent Line Treatment in Patients With Metastatic Renal Cell Carcinoma: Data From the Polish Managed Access Program
|
Bodnar, Lubomir
|
|
2019
|
17 |
3 |
p. e556-e564
|
artikel
|
| 44 |
Red Cell Distribution Width Predicts Prostate-Specific Antigen Response and Survival of Patients With Castration-Resistant Prostate Cancer Treated With Androgen Receptor Axis–Targeted Agents
|
Fukuokaya, Wataru
|
|
2019
|
17 |
3 |
p. 223-230
|
artikel
|
| 45 |
Rise in Node-Positive Prostate Cancer Incidence in Context of Evolving Use and Extent of Pelvic Lymphadenectomy
|
Taylor, Melissa A.
|
|
2019
|
17 |
3 |
p. e494-e504
|
artikel
|
| 46 |
Role of Biomarkers in Prediction of Response to Therapeutics in Metastatic Renal-Cell Carcinoma
|
Adashek, Jacob J.
|
|
2019
|
17 |
3 |
p. e454-e460
|
artikel
|
| 47 |
Salvage Surgery After Percutaneous Ablation of Renal Mass in Solitary Kidney in a Patient With Von Hippel-Lindau
|
Gomella, Patrick T.
|
|
2019
|
17 |
3 |
p. e482-e484
|
artikel
|
| 48 |
Sarcomatoid Renal Cell Carcinoma: Population-Based Study of 879 Patients
|
Alevizakos, Michail
|
|
2019
|
17 |
3 |
p. e447-e453
|
artikel
|
| 49 |
Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
|
Lyon, Timothy D.
|
|
2019
|
17 |
3 |
p. 216-222.e5
|
artikel
|
| 50 |
Stereotactic Radiation Therapy for Renal Cell Carcinoma Brain Metastases in the Tyrosine Kinase Inhibitors Era: Outcomes of 120 Patients
|
Klausner, Guillaume
|
|
2019
|
17 |
3 |
p. 191-200
|
artikel
|
| 51 |
Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma
|
Nazzani, Sebastiano
|
|
2019
|
17 |
3 |
p. e602-e611
|
artikel
|
| 52 |
Synchronous Bilateral RCC Is Associated With Poor Recurrence-Free Survival Compared With Unilateral RCC: A Single-Center Study With Propensity Score Matching Analysis
|
Kim, Jung Kwon
|
|
2019
|
17 |
3 |
p. e570-e580
|
artikel
|
| 53 |
Table of Contents
|
|
|
2019
|
17 |
3 |
p. A7-A15
|
artikel
|
| 54 |
Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non–Muscle-Invasive Bladder Cancer
|
Xu, Yanjie
|
|
2019
|
17 |
3 |
p. e704-e711
|
artikel
|
| 55 |
Use of Radium-223 Dichloride in Patients With Osteonecrosis of the Jaw Induced by Zoledronic Acid: Report of 2 Cases
|
Dionisi, Valeria
|
|
2019
|
17 |
3 |
p. e612-e617
|
artikel
|
| 56 |
Who Can Avoid Systematic Biopsy Without Missing Clinically Significant Prostate Cancer in Men Who Undergo Magnetic Resonance Imaging-Targeted Biopsy?
|
Nakanishi, Yasukazu
|
|
2019
|
17 |
3 |
p. e664-e671
|
artikel
|
Tijdschrift beschrijving